PREDICTING THE RISK OF PATIENT DETERIORATION

CLEW offers the first FDA-cleared, AI-based clinical predictive models for high-acuity care. With an optimal balance of precision and sensitivity, its peer-reviewed predictive insights have been documented to be at least five times more accurate than other systems.

Learn more about our FDA Clearance.

Read Now

CREATING OPPORTUNITIES FOR EARLY INTERVENTION

With truly accurate predictions of patient deterioration, up to eight hours before patient monitoring systems would suspect, CLEW gives hospitals and health systems the opportunity for early intervention. This leads to decreases in mortality and reductions in complications and readmissions.

IMPROVING OPERATIONAL AND CLINICAL OUTCOMES 

Early identification of patient deterioration allows caregivers time to intervene proactively, which leads to decreases in unforeseen bottlenecks, reducing length of stay, improving capacity management and access to care. 

Proven Superior Accuracy & Efficiency

READ THE CHEST JOURNAL STUDY

5x more
accurate

A CHEST Journal study found CLEW notifications to be 5 times more accurate than the leading telemedicine system. Learn more about the peer-reviewed study on the efficiency of our prediction models here.

View more News
NEW STUDY FINDS AI-DRIVEN PREDICTION MODELS ACCURATELY PREDICT CRITICAL CARE PATIENT DETERIORATION AND SIGNIFICANTLY REDUCE FALSE ALARMS FOR CLINICIANS
A scientific paper recently published by CHEST Journal, shares a study that finds CLEW Medical’s FDA-cleared AI-driven models for predicting patient deterioration were five times more accurate than alerts from a leading telemedicine system. from NEW STUDY FINDS AI-DRIVEN PREDICTION MODELS ACCURATELY PREDICT CRITICAL CARE PATIENT DETERIORATION AND SIGNIFICANTLY REDUCE FALSE ALARMS FOR CLINICIANS

Read More
AI in High-Acuity Telehealth Care: The CLEW AI and Equum Medical Partnership
AI in High-Acuity Telehealth Care: The CLEW AI and Equum Medical Partnership from AI in High-Acuity Telehealth Care: The CLEW AI and Equum Medical Partnership

Read More
CLEW Announces Tele-ICU Conversion and Accelerator Program
Rapid and risk-free migration from legacy Philips eICU® to CLEW's FDA-cleared AI Tele-ICU platform from CLEW Announces Tele-ICU Conversion and Accelerator Program

Read More
CLEW announces appointment of Paul Roscoe as CEO
CLEW, a provider of real-time AI analytics platforms for healthcare, today announced that its board of directors has named Paul Roscoe as its new CEO, responsible for leading the growth of CLEW worldwide. from CLEW announces appointment of Paul Roscoe as CEO

Read More

Widespread Challenges in Healthcare

RISING PATIENT ACUITY

Greater percentage of high-acuity patients require extensive care resources

CLINICIAN SHORTAGE

Staff arrives increasingly less experienced on systems, workflows and clinical protocols

CAPACITY CONSTRAINTS

Unforeseen patient deterioration leads to increases in length of stay

Empowering Health Systems & Providers

Learn about improving patient outcomes for your organization.

Explore

ALLOWS FOR EARLY INTERVENTION

Provides caregivers insights based on real-time patient physiology

DRIVES PROACTIVE CLINICAL EXCELLENCE

Enables decision support for complex clinical scenarios

ENABLES RESOURCE OPTIMIZATION

Leaders have advanced clinical insights when making staffing assignments

REDUCES NURSING BURNOUT

Fewer alerts and false alarms results in fewer disruptions for caregivers

IMPROVES ACCESS TO CARE

Early intervention leads to reduced length of stay and increased capacity

Receive the latest updates from CLEW

"*" indicates required fields

Name*

Selected Partners

Selected Customers